United States · FDA National Drug Code directory
Triazolam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50742-646_22a3bdbc-8edf-45a5-ad5c-4a0c3f73f255
- Product NDC
- 50742-646
- Form
- TABLET
- Composition / generic term
- Triazolam
- Labeler
- Ingenus Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201020
- Source listing expiry
- 20261231
Source-listed ingredients
- TRIAZOLAM — .25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (50742-646-01) · 50742-646-01
- 500 TABLET in 1 BOTTLE, PLASTIC (50742-646-05) · 50742-646-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →